Vivani Medical (VANI) Accumulated Expenses (2014 - 2026)
Vivani Medical (VANI) posted quarterly Accumulated Expenses of $1.7 million for Q1 2026, up 378.57% year-over-year from $350000.0 in Q1 2025, and up 358.9% quarter-over-quarter from $365000.0 in Q4 2025.
Vivani Medical (VANI) Accumulated Expenses (2014 - 2026) Analysis & Trends
Vivani Medical's Accumulated Expenses history runs 13 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 378.57% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 378.57% YoY), while the FY2025 annual figure was $365000.0, down 78.21% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $1.7 million, up from $365000.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $2.4 million in Q4 2022, with the low at $350000.0 in Q1 2025.
- The 5-year median for Accumulated Expenses is $676000.0 (2023), against an average of $1.0 million.
- The sharpest annual moves came in 2023 and 2026: Accumulated Expenses tumbled 83.21% in 2023, then jumped 378.57% in 2026.
- Vivani Medical's Accumulated Expenses stood at $2.4 million in 2022, then sank by 83.21% to $396000.0 in 2023, then jumped by 322.98% to $1.7 million in 2024, then slumped by 78.21% to $365000.0 in 2025, then surged by 358.9% to $1.7 million in 2026.
- Business Quant data shows VANI's Accumulated Expenses at $1.7 million in Q1 2026, $365000.0 in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.68 Mn |
| Mar 31, 2026 | 1.68 Mn |
| Dec 31, 2025 | 365,000.00 |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 356,000.00 |
| Mar 31, 2025 | 350,000.00 |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 384,000.00 |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2023 | 396,000.00 |
| Sep 30, 2023 | 676,000.00 |
| Jun 30, 2023 | 567,000.00 |
| Mar 31, 2023 | 415,000.00 |
| Dec 31, 2022 | 2.36 Mn |
| Sep 30, 2022 | 1.85 Mn |
| Jun 30, 2022 | 796,000.00 |
| Mar 31, 2022 | 462,000.00 |
| Dec 31, 2021 | 895,000.00 |
| Sep 30, 2021 | 575,000.00 |